188 related articles for article (PubMed ID: 24338900)
1. Inhibitory effect of valsartan on the intestinal absorption and renal excretion of bestatin in rats.
Huo X; Liu Q; Wang C; Meng Q; Sun H; Peng J; Ma X; Sun P; Liu K
J Pharm Sci; 2014 Feb; 103(2):719-29. PubMed ID: 24338900
[TBL] [Abstract][Full Text] [Related]
2. PEPT1- and OAT1/3-mediated drug-drug interactions between bestatin and cefixime in vivo and in vitro in rats, and in vitro in human.
Wang L; Wang C; Liu Q; Meng Q; Huo X; Sun P; Yang X; Sun H; Zhen Y; Peng J; Ma X; Liu K
Eur J Pharm Sci; 2014 Oct; 63():77-86. PubMed ID: 25016073
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate-bestatin interaction: involvement of P-glycoprotein and organic anion transporters in rats.
Zhu Y; Meng Q; Wang C; Liu Q; Huo X; Zhang A; Sun P; Sun H; Li H; Liu K
Int J Pharm; 2014 Apr; 465(1-2):368-77. PubMed ID: 24530518
[TBL] [Abstract][Full Text] [Related]
4. Organic anion transporters involved in the excretion of bestatin in the kidney.
Zhu Y; Meng Q; Wang C; Liu Q; Sun H; Kaku T; Liu K
Peptides; 2012 Feb; 33(2):265-71. PubMed ID: 22273603
[TBL] [Abstract][Full Text] [Related]
5. OAT1 and OAT3: targets of drug-drug interaction between entecavir and JBP485.
Xu Q; Wang C; Meng Q; Liu Q; Sun H; Peng J; Ma X; Kaku T; Liu K
Eur J Pharm Sci; 2013 Mar; 48(4-5):650-7. PubMed ID: 23313623
[TBL] [Abstract][Full Text] [Related]
6. Peptide cotransporter 1 in intestine and organic anion transporters in kidney are targets of interaction between JBP485 and lisinopril in rats.
Guo X; Meng Q; Liu Q; Wang C; Mao Q; Sun H; Peng J; Kaku T; Liu K
Drug Metab Pharmacokinet; 2012; 27(2):232-41. PubMed ID: 22123131
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic interaction study between quercetin and valsartan in rats and in vitro models.
Challa VR; Babu PR; Challa SR; Johnson B; Maheswari C
Drug Dev Ind Pharm; 2013 Jun; 39(6):865-72. PubMed ID: 22670860
[TBL] [Abstract][Full Text] [Related]
8. Effects of 1α,25-dihydroxyvitamin D3 , the natural vitamin D receptor ligand, on the pharmacokinetics of cefdinir and cefadroxil, organic anion transporter substrates, in rat.
Kim YC; Kim IB; Noh CK; Quach HP; Yoon IS; Chow ECY; Kim M; Jin HE; Cho KH; Chung SJ; Pang KS; Maeng HJ
J Pharm Sci; 2014 Nov; 103(11):3793-3805. PubMed ID: 25266751
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of JBP485 on renal excretion of acyclovir by the inhibition of OAT1 and OAT3.
Ye J; Liu Q; Wang C; Meng Q; Peng J; Sun H; Kaku T; Liu K
Eur J Pharm Sci; 2012 Sep; 47(2):341-6. PubMed ID: 22728397
[TBL] [Abstract][Full Text] [Related]
10. Enhancement effect of P-gp inhibitors on the intestinal absorption and antiproliferative activity of bestatin.
Huo X; Liu Q; Wang C; Meng Q; Sun H; Peng J; Ma X; Liu K
Eur J Pharm Sci; 2013 Nov; 50(3-4):420-8. PubMed ID: 23981338
[TBL] [Abstract][Full Text] [Related]
11. High-affinity interaction of sartans with H+/peptide transporters.
Knütter I; Kottra G; Fischer W; Daniel H; Brandsch M
Drug Metab Dispos; 2009 Jan; 37(1):143-9. PubMed ID: 18824524
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic interaction between JBP485 and cephalexin in rats.
Zhang J; Wang C; Liu Q; Meng Q; Cang J; Sun H; Gao Y; Kaku T; Liu K
Drug Metab Dispos; 2010 Jun; 38(6):930-8. PubMed ID: 20219852
[TBL] [Abstract][Full Text] [Related]
13. Aspirin and probenecid inhibit organic anion transporter 3-mediated renal uptake of cilostazol and probenecid induces metabolism of cilostazol in the rat.
Wang C; Wang C; Liu Q; Meng Q; Cang J; Sun H; Peng J; Ma X; Huo X; Liu K
Drug Metab Dispos; 2014 Jun; 42(6):996-1007. PubMed ID: 24692216
[TBL] [Abstract][Full Text] [Related]
14. Prediction of pharmacokinetic profile of valsartan in humans based on in vitro uptake-transport data.
Poirier A; Cascais AC; Funk C; Lavé T
Chem Biodivers; 2009 Nov; 6(11):1975-87. PubMed ID: 19937834
[TBL] [Abstract][Full Text] [Related]
15. Bezafibrate-mizoribine interaction: Involvement of organic anion transporters OAT1 and OAT3 in rats.
Feng Y; Wang C; Liu Q; Meng Q; Huo X; Liu Z; Sun P; Yang X; Sun H; Qin J; Liu K
Eur J Pharm Sci; 2016 Jan; 81():119-28. PubMed ID: 26474691
[TBL] [Abstract][Full Text] [Related]
16. Prediction of pharmacokinetic profile of valsartan in human based on in vitro uptake transport data.
Poirier A; Cascais AC; Funk C; Lavé T
J Pharmacokinet Pharmacodyn; 2009 Dec; 36(6):585-611. PubMed ID: 19936896
[TBL] [Abstract][Full Text] [Related]
17. Renal uptake of substrates for organic anion transporters Oat1 and Oat3 and organic cation transporters Oct1 and Oct2 is altered in rats with adenine-induced chronic renal failure.
Komazawa H; Yamaguchi H; Hidaka K; Ogura J; Kobayashi M; Iseki K
J Pharm Sci; 2013 Mar; 102(3):1086-94. PubMed ID: 23280877
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of 1α,25-dihydroxyvitamin D₃ on excretion of JBP485 via organic anion transporters in rats.
Miao Q; Liu Q; Wang C; Meng Q; Guo X; Sun H; Peng J; Ma X; Kaku T; Liu K
Eur J Pharm Sci; 2013 Jan; 48(1-2):351-9. PubMed ID: 23201003
[TBL] [Abstract][Full Text] [Related]
19. Benzylpenicillin inhibits the renal excretion of acyclovir by OAT1 and OAT3.
Ye J; Liu Q; Wang C; Meng Q; Sun H; Peng J; Ma X; Liu K
Pharmacol Rep; 2013; 65(2):505-12. PubMed ID: 23744435
[TBL] [Abstract][Full Text] [Related]
20. OAT3 Participates in Drug-Drug Interaction between Bentysrepinine and Entecavir through Interactions with M8-A Metabolite of Bentysrepinine-In Rats and Humans In Vitro.
Zhang A; Yang F; Yuan Y; Li C; Huo X; Liu J; Zhou S; Li W; Zhang N; Liu J; Dong S; Fan H; Peng Y; Zheng J
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]